These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 8383394

  • 1. Expression of the Epstein-Barr virus (EBV) latent membrane protein is tightly regulated, independently of EB nuclear antigen 2 and of EBV integration or copy number.
    Cordier-Bussat M, Calender A, Vuillaume M, Bornkamm GW, Lenoir GM.
    Virus Res; 1993 Jan; 27(1):55-69. PubMed ID: 8383394
    [Abstract] [Full Text] [Related]

  • 2. Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23.
    Cordier M, Calender A, Billaud M, Zimber U, Rousselet G, Pavlish O, Banchereau J, Tursz T, Bornkamm G, Lenoir GM.
    J Virol; 1990 Mar; 64(3):1002-13. PubMed ID: 2154588
    [Abstract] [Full Text] [Related]

  • 3. Identification and characterization of an Epstein-Barr virus nuclear antigen 2-responsive cis element in the bidirectional promoter region of latent membrane protein and terminal protein 2 genes.
    Laux G, Dugrillon F, Eckert C, Adam B, Zimber-Strobl U, Bornkamm GW.
    J Virol; 1994 Nov; 68(11):6947-58. PubMed ID: 7933076
    [Abstract] [Full Text] [Related]

  • 4. Analysis of viral gene expression and genome persistence in CD23-positive and -negative subpopulations of Epstein-Barr-virus-infected BL2 cells.
    Doyle MG, Crawford DH.
    Intervirology; 1994 Nov; 37(5):236-44. PubMed ID: 7698878
    [Abstract] [Full Text] [Related]

  • 5. Correlation of the expression of Epstein-Barr virus latent membrane protein and in situ hybridization with biotinylated BamHI-W probes in Hodgkin's disease.
    Delsol G, Brousset P, Chittal S, Rigal-Huguet F.
    Am J Pathol; 1992 Feb; 140(2):247-53. PubMed ID: 1310829
    [Abstract] [Full Text] [Related]

  • 6. Epstein-Barr virus nuclear antigen 2 induces expression of the virus-encoded latent membrane protein.
    Abbot SD, Rowe M, Cadwallader K, Ricksten A, Gordon J, Wang F, Rymo L, Rickinson AB.
    J Virol; 1990 May; 64(5):2126-34. PubMed ID: 2157875
    [Abstract] [Full Text] [Related]

  • 7. Different patterns of Epstein-Barr virus gene expression and of cytotoxic T-cell recognition in B-cell lines infected with transforming (B95.8) or nontransforming (P3HR1) virus strains.
    Murray RJ, Young LS, Calender A, Gregory CD, Rowe M, Lenoir GM, Rickinson AB.
    J Virol; 1988 Mar; 62(3):894-901. PubMed ID: 2828684
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
    Rowe M, Khanna R, Jacob CA, Argaet V, Kelly A, Powis S, Belich M, Croom-Carter D, Lee S, Burrows SR.
    Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Expression of the Epstein-Barr virus (EBV)-encoded membrane antigen (LMP) increases the stimulatory capacity of EBV-negative B lymphoma lines in allogeneic mixed lymphocyte cultures.
    Cuomo L, Trivedi P, Wang F, Winberg G, Klein G, Masucci MG.
    Eur J Immunol; 1990 Oct; 20(10):2293-9. PubMed ID: 2173662
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Marked, transient inhibition of expression of the Epstein-Barr virus latent membrane protein gene in Burkitt's lymphoma cell lines by electroporation.
    Gahn TA, Sugden B.
    J Virol; 1993 Nov; 67(11):6379-86. PubMed ID: 8411339
    [Abstract] [Full Text] [Related]

  • 17. Infection of leukaemic B lymphocytes by Epstein Barr virus.
    Doyle MG, Catovsky D, Crawford DH.
    Leukemia; 1993 Nov; 7(11):1858-64. PubMed ID: 8231253
    [Abstract] [Full Text] [Related]

  • 18. [The EBNA2 coding region in the viral genome of Epstein-Barr virus (EBV)-positive cases of Hodgkin's disease].
    Borisch B, Telenti A, Hennig I, Marchesi F, Audouin J, Diebold J, Pallesen G.
    Verh Dtsch Ges Pathol; 1992 Nov; 76():181-4. PubMed ID: 1336913
    [Abstract] [Full Text] [Related]

  • 19. The Epstein-Barr virus nuclear antigen 2 interacts with an EBNA2 responsive cis-element of the terminal protein 1 gene promoter.
    Zimber-Strobl U, Kremmer E, Grässer F, Marschall G, Laux G, Bornkamm GW.
    EMBO J; 1993 Jan; 12(1):167-75. PubMed ID: 8381349
    [Abstract] [Full Text] [Related]

  • 20. Down-regulation of integrated Epstein-Barr virus nuclear antigen 1 and 2 genes in a Burkitt lymphoma cell line after somatic cell fusion with autologous EBV-immortalized lymphoblastoid cells.
    Wolf J, Pawlita M, Klevenz B, Frech B, Freese UK, Müller-Lantzsch N, Diehl V, zur Hausen H.
    Int J Cancer; 1993 Feb 20; 53(4):621-7. PubMed ID: 8382194
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.